SERPINE1 Gene Plasminogen Activator Inhibitor Type 1 Genetic Test
Cost: AED 4400.0
Symptoms, Diagnosis, and Test Details
The SERPINE1 gene is responsible for encoding the plasminogen activator inhibitor type 1 (PAI-1) protein. PAI-1 is a protein that inhibits the activity of plasminogen activators, which are enzymes that convert plasminogen into plasmin. Plasmin is involved in the breakdown of blood clots.
An NGS (Next-Generation Sequencing) genetic test for the SERPINE1 gene can analyze the DNA sequence of this gene to identify any variations or mutations that may be present. These variations can affect the function of the PAI-1 protein and may be associated with various health conditions.
Testing for variations in the SERPINE1 gene can be useful in assessing the risk of thrombotic disorders, such as deep vein thrombosis (DVT) and pulmonary embolism. Certain mutations in the SERPINE1 gene have been associated with increased levels of PAI-1 and an increased risk of thrombotic events.
NGS genetic testing allows for the analysis of multiple genes simultaneously, providing a comprehensive view of an individual’s genetic makeup. This type of testing can help identify individuals who may be at increased risk for certain diseases or conditions, allowing for early intervention or preventative measures.
Test Components and Price
- Test Name: SERPINE1 Gene Plasminogen Activator Inhibitor Type 1 Genetic Test
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Vascular Diseases
- Doctor: General Physician
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for SERPINE1 Gene Plasminogen Activator Inhibitor Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SERPINE1 Gene Plasminogen Activator Inhibitor Type 1 NGS Genetic DNA Test gene SERPINE1
Interpreting Test Results
It’s important to note that genetic testing results should always be interpreted in conjunction with other clinical information and in consultation with a healthcare professional or genetic counselor. They can provide personalized recommendations based on an individual’s genetic test results and medical history.
| Test Name | SERPINE1 Gene Plasminogen activator inhibitor type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Vascular Diseases |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SERPINE1 Gene Plasminogen activator inhibitor type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SERPINE1 Gene Plasminogen activator inhibitor type 1 NGS Genetic DNA Test gene SERPINE1 |
| Test Details | The SERPINE1 gene is responsible for encoding the plasminogen activator inhibitor type 1 (PAI-1) protein. PAI-1 is a protein that inhibits the activity of plasminogen activators, which are enzymes that convert plasminogen into plasmin. Plasmin is involved in the breakdown of blood clots. An NGS (Next-Generation Sequencing) genetic test for the SERPINE1 gene can analyze the DNA sequence of this gene to identify any variations or mutations that may be present. These variations can affect the function of the PAI-1 protein and may be associated with various health conditions. Testing for variations in the SERPINE1 gene can be useful in assessing the risk of thrombotic disorders, such as deep vein thrombosis (DVT) and pulmonary embolism. Certain mutations in the SERPINE1 gene have been associated with increased levels of PAI-1 and an increased risk of thrombotic events. NGS genetic testing allows for the analysis of multiple genes simultaneously, providing a comprehensive view of an individual’s genetic makeup. This type of testing can help identify individuals who may be at increased risk for certain diseases or conditions, allowing for early intervention or preventative measures. It’s important to note that genetic testing results should always be interpreted in conjunction with other clinical information and in consultation with a healthcare professional or genetic counselor. They can provide personalized recommendations based on an individual’s genetic test results and medical history. |
